FHLC vs. IHE
FHLC (Fidelity MSCI Health Care Index ETF) and IHE (iShares U.S. Pharmaceuticals ETF) are both Health & Biotech Equities funds - FHLC tracks the MSCI USA IMI Health Care Index while IHE tracks the Dow Jones U.S. Select Pharmaceuticals Index. Both are passively managed. Over the past 10 years, FHLC returned 9.14%/yr vs 7.81%/yr for IHE. Their correlation of 0.87 suggests significant overlap in exposure. FHLC charges 0.08%/yr vs 0.42%/yr for IHE.
Performance
FHLC vs. IHE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FHLC achieves a -3.90% return, which is significantly lower than IHE's 6.47% return. Over the past 10 years, FHLC has outperformed IHE with an annualized return of 9.14%, while IHE has yielded a comparatively lower 7.81% annualized return.
FHLC
- 1D
- 0.82%
- 1M
- 1.50%
- YTD
- -3.90%
- 6M
- -4.11%
- 1Y
- 14.43%
- 3Y*
- 6.14%
- 5Y*
- 4.50%
- 10Y*
- 9.14%
IHE
- 1D
- 1.16%
- 1M
- 1.80%
- YTD
- 6.47%
- 6M
- 8.51%
- 1Y
- 40.15%
- 3Y*
- 17.47%
- 5Y*
- 9.98%
- 10Y*
- 7.81%
FHLC vs. IHE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | -3.90% | 15.42% | 2.48% | 2.58% | -5.55% | 20.39% | 18.13% | 21.94% | 4.71% | 23.34% |
IHE iShares U.S. Pharmaceuticals ETF | 6.47% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
Correlation
The correlation between FHLC and IHE is 0.87, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.87 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.85 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.85 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.86 |
Correlation (All Time) Calculated using the full available price history since Oct 25, 2013 | 0.87 |
The correlation between FHLC and IHE has been stable across timeframes, ranging from 0.85 to 0.87 - a consistent structural relationship.
FHLC vs. IHE - Sectors Allocation Comparison
Sectors
FHLC
IHE
Healthcare
Financial Services
-
Technology
-
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
FHLC
IHE
Financial Services
FHLC
IHE
-
Technology
FHLC
IHE
-
Industrials
FHLC
IHE
-
Basic Materials
FHLC
-
IHE
-
Communication Services
FHLC
-
IHE
-
Consumer Cyclical
FHLC
-
IHE
-
Consumer Defensive
FHLC
-
IHE
-
Energy
FHLC
-
IHE
-
Real Estate
FHLC
-
IHE
-
Utilities
FHLC
-
IHE
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FHLC vs. IHE — Risk / Return Rank
FHLC
IHE
FHLC vs. IHE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity MSCI Health Care Index ETF (FHLC) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FHLC | IHE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.35 | ||
| Sortino ratioReturn per unit of downside risk | -1.85 | ||
| Omega ratioGain probability vs. loss probability | 1.18 | 1.40 | -0.22 |
| Calmar ratioReturn relative to maximum drawdown | 1.40 | 4.76 | -3.37 |
| Martin ratioReturn relative to average drawdown | 3.52 | 14.35 | -10.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FHLC | IHE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.01 | 2.36 | -1.35 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.30 | 0.62 | -0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.55 | 0.43 | +0.11 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.61 | 0.51 | +0.10 |
Drawdowns
FHLC vs. IHE - Drawdown Comparison
The maximum FHLC drawdown since its inception was -28.76%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for FHLC and IHE.
Loading charts...
Drawdown Indicators
| FHLC | IHE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -28.76% | -38.20% | +9.44% |
Max Drawdown (1Y)Largest decline over 1 year | -10.38% | -8.47% | -1.91% |
Max Drawdown (3Y)Largest decline over 3 years | -16.87% | -15.92% | -0.95% |
Max Drawdown (5Y)Largest decline over 5 years | -17.73% | -16.03% | -1.70% |
Max Drawdown (10Y)Largest decline over 10 years | -28.76% | -29.59% | +0.83% |
Current DrawdownCurrent decline from peak | -6.96% | -2.80% | -4.16% |
Average DrawdownAverage peak-to-trough decline | -5.19% | -7.92% | +2.73% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.11% | 2.81% | +1.30% |
Volatility
FHLC vs. IHE - Volatility Comparison
The current volatility for Fidelity MSCI Health Care Index ETF (FHLC) is 4.05%, while iShares U.S. Pharmaceuticals ETF (IHE) has a volatility of 5.53%. This indicates that FHLC experiences smaller price fluctuations and is considered to be less risky than IHE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FHLC | IHE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.05% | 5.53% | -1.48% |
Volatility (6M)Calculated over the trailing 6-month period | 10.11% | 12.48% | -2.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.33% | 17.07% | -2.74% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.97% | 16.24% | -1.27% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.81% | 18.05% | -1.24% |
FHLC vs. IHE - Expense Ratio Comparison
FHLC has a 0.08% expense ratio, which is lower than IHE's 0.42% expense ratio.
Dividends
FHLC vs. IHE - Dividend Comparison
FHLC's dividend yield for the trailing twelve months is around 1.43%, less than IHE's 1.65% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FHLC Fidelity MSCI Health Care Index ETF | 1.43% | 1.40% | 1.51% | 1.40% | 1.30% | 1.16% | 1.45% | 1.18% | 1.38% | 1.38% | 1.40% | 2.07% |
IHE iShares U.S. Pharmaceuticals ETF | 1.65% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
Frequently Asked Questions
FHLC and IHE have a correlation of 0.87, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IHE has higher volatility (5.53%) compared to FHLC (4.05%). In terms of maximum drawdown, FHLC dropped -28.76% vs IHE's -38.20%.
On 10-year performance, FHLC leads with 9.14% vs 7.81% for IHE. On fees, FHLC is cheaper at 0.08% per year. On volatility, FHLC has been the lower-risk option at 4.05%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FHLC has performed better with a 9.14% return vs 7.81%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FHLC is cheaper with a 0.08% expense ratio, compared with 0.42% for IHE.
IHE has the higher dividend yield at 1.65%, compared with 1.43% for FHLC.
FHLC tracks MSCI USA IMI Health Care Index, while IHE tracks Dow Jones U.S. Select Pharmaceuticals Index. They also come from different issuers: Fidelity and iShares. Their fees differ too: 0.08% for FHLC and 0.42% for IHE.
IHE currently has the higher Sharpe Ratio (2.36 vs 1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FHLC and IHE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer